A representative from the Drug Administration of Vietnam confirmed on 25/3 that no product named YEZTUGO (lenacapavir) injection 463,5 mg/1,5 ml is registered for domestic circulation, following a review of drug registration data.
This warning follows reports received by authorities concerning the buying, selling, and supply of counterfeit HIV pre-exposure prophylaxis (PrEP) drugs, which falsely carry the Gilead brand.
 |
Image of the counterfeit drug. Photo: Drug Administration of Vietnam
The Drug Administration of Vietnam has directed Provincial Departments of Health to alert drug businesses, healthcare providers, and the public to refrain from purchasing or using the product. They are also instructed to promptly report any suspected counterfeit drugs or those of unknown origin. Furthermore, localities are urged to intensify inspections and supervision, collaborating with relevant agencies to verify the origin of drugs on the market and to strictly penalize any violations. The Ho Chi Minh City Department of Health has been specifically tasked with continuing to verify and address information related to this suspected counterfeit product.
The Ministry of Health also called on all localities to bolster controls and prevent smuggling, commercial fraud, and the circulation of counterfeit drugs within the health sector.
Le Nga
